Harga Saham

Tanggal	Shanghai Fosun Pharmaceutical Group Co Pendapatan	Shanghai Fosun Pharmaceutical Group Co EBIT	Shanghai Fosun Pharmaceutical Group Co Laba
2026e	53,25 miliar undefined	2,71 miliar undefined	3,67 miliar undefined
2025e	49,15 miliar undefined	2,75 miliar undefined	3,24 miliar undefined
2024e	45,24 miliar undefined	2,41 miliar undefined	2,78 miliar undefined
2023	41,40 miliar undefined	1,29 miliar undefined	2,39 miliar undefined
2022	43,95 miliar undefined	3,50 miliar undefined	3,73 miliar undefined
2021	39,01 miliar undefined	2,55 miliar undefined	4,74 miliar undefined
2020	30,31 miliar undefined	2,64 miliar undefined	3,66 miliar undefined
2019	28,59 miliar undefined	2,49 miliar undefined	3,32 miliar undefined
2018	24,92 miliar undefined	2,29 miliar undefined	2,71 miliar undefined
2017	18,53 miliar undefined	2,24 miliar undefined	3,12 miliar undefined
2016	14,63 miliar undefined	1,64 miliar undefined	2,81 miliar undefined
2015	12,61 miliar undefined	1,36 miliar undefined	2,46 miliar undefined
2014	12,03 miliar undefined	1,11 miliar undefined	2,11 miliar undefined
2013	10,00 miliar undefined	1,03 miliar undefined	1,58 miliar undefined
2012	7,34 miliar undefined	553,00 Juta. undefined	1,56 miliar undefined
2011	6,49 miliar undefined	324,00 Juta. undefined	1,17 miliar undefined
2010	4,56 miliar undefined	163,00 Juta. undefined	864,00 Juta. undefined
2009	3,87 miliar undefined	157,00 Juta. undefined	2,50 miliar undefined
2008	3,77 miliar undefined	118,00 Juta. undefined	691,00 Juta. undefined
2007	3,69 miliar undefined	164,00 Juta. undefined	626,00 Juta. undefined
2006	4,08 miliar undefined	92,00 Juta. undefined	258,00 Juta. undefined
2005	2,99 miliar undefined	143,00 Juta. undefined	159,00 Juta. undefined
2004	2,43 miliar undefined	153,00 Juta. undefined	215,00 Juta. undefined

	Pendapatan	EBIT	Laba
2004	2,43 miliar CNY	153,00 Juta. CNY	215,00 Juta. CNY
2005	2,99 miliar CNY	143,00 Juta. CNY	159,00 Juta. CNY
2006	4,08 miliar CNY	92,00 Juta. CNY	258,00 Juta. CNY
2007	3,69 miliar CNY	164,00 Juta. CNY	626,00 Juta. CNY
2008	3,77 miliar CNY	118,00 Juta. CNY	691,00 Juta. CNY
2009	3,87 miliar CNY	157,00 Juta. CNY	2,50 miliar CNY
2010	4,56 miliar CNY	163,00 Juta. CNY	864,00 Juta. CNY
2011	6,49 miliar CNY	324,00 Juta. CNY	1,17 miliar CNY
2012	7,34 miliar CNY	553,00 Juta. CNY	1,56 miliar CNY
2013	10,00 miliar CNY	1,03 miliar CNY	1,58 miliar CNY
2014	12,03 miliar CNY	1,11 miliar CNY	2,11 miliar CNY
2015	12,61 miliar CNY	1,36 miliar CNY	2,46 miliar CNY
2016	14,63 miliar CNY	1,64 miliar CNY	2,81 miliar CNY
2017	18,53 miliar CNY	2,24 miliar CNY	3,12 miliar CNY
2018	24,92 miliar CNY	2,29 miliar CNY	2,71 miliar CNY
2019	28,59 miliar CNY	2,49 miliar CNY	3,32 miliar CNY
2020	30,31 miliar CNY	2,64 miliar CNY	3,66 miliar CNY
2021	39,01 miliar CNY	2,55 miliar CNY	4,74 miliar CNY
2022	43,95 miliar CNY	3,50 miliar CNY	3,73 miliar CNY
2023	41,40 miliar CNY	1,29 miliar CNY	2,39 miliar CNY
2024e	45,24 miliar CNY	2,41 miliar CNY	2,78 miliar CNY
2025e	49,15 miliar CNY	2,75 miliar CNY	3,24 miliar CNY
2026e	53,25 miliar CNY	2,71 miliar CNY	3,67 miliar CNY

Shanghai Fosun Pharmaceutical Group Co Margin Kotor	Shanghai Fosun Pharmaceutical Group Co Margin Laba	Shanghai Fosun Pharmaceutical Group Co Margin EBIT	Shanghai Fosun Pharmaceutical Group Co Margin Laba
2026e	47,54 %	5,09 %	6,90 %
2025e	47,54 %	5,59 %	6,58 %
2024e	47,54 %	5,33 %	6,15 %
2023	47,54 %	3,11 %	5,76 %
2022	47,09 %	7,97 %	8,49 %
2021	47,97 %	6,54 %	12,14 %
2020	55,47 %	8,72 %	12,09 %
2019	59,57 %	8,71 %	11,62 %
2018	58,34 %	9,17 %	10,87 %
2017	58,84 %	12,06 %	16,86 %
2016	53,81 %	11,23 %	19,18 %
2015	49,78 %	10,81 %	19,51 %
2014	43,87 %	9,19 %	17,57 %
2013	44,22 %	10,30 %	15,84 %
2012	43,62 %	7,53 %	21,31 %
2011	37,63 %	5,00 %	17,98 %
2010	33,90 %	3,58 %	18,97 %
2009	32,02 %	4,05 %	64,51 %
2008	27,67 %	3,13 %	18,31 %
2007	26,59 %	4,44 %	16,95 %
2006	21,34 %	2,25 %	6,32 %
2005	29,98 %	4,78 %	5,32 %
2004	31,22 %	6,31 %	8,87 %

	Margin Kotor	Margin EBIT	Margin Laba
2004	31,22 %	6,31 %	8,87 %
2005	29,98 %	4,78 %	5,32 %
2006	21,34 %	2,25 %	6,32 %
2007	26,59 %	4,44 %	16,95 %
2008	27,67 %	3,13 %	18,31 %
2009	32,02 %	4,05 %	64,51 %
2010	33,90 %	3,58 %	18,97 %
2011	37,63 %	5,00 %	17,98 %
2012	43,62 %	7,53 %	21,31 %
2013	44,22 %	10,30 %	15,84 %
2014	43,87 %	9,19 %	17,57 %
2015	49,78 %	10,81 %	19,51 %
2016	53,81 %	11,23 %	19,18 %
2017	58,84 %	12,06 %	16,86 %
2018	58,34 %	9,17 %	10,87 %
2019	59,57 %	8,71 %	11,62 %
2020	55,47 %	8,72 %	12,09 %
2021	47,97 %	6,54 %	12,14 %
2022	47,09 %	7,97 %	8,49 %
2023	47,54 %	3,11 %	5,76 %
2024e	47,54 %	5,33 %	6,15 %
2025e	47,54 %	5,59 %	6,58 %
2026e	47,54 %	5,09 %	6,90 %

Tanggal	Shanghai Fosun Pharmaceutical Group Co Pendapatan per Saham	Shanghai Fosun Pharmaceutical Group Co EBIT per Saham	Shanghai Fosun Pharmaceutical Group Co Laba per Saham
2026e	25,16 undefined	0 undefined	1,73 undefined
2025e	23,22 undefined	0 undefined	1,53 undefined
2024e	21,37 undefined	0 undefined	1,31 undefined
2023	15,51 undefined	0,48 undefined	0,89 undefined
2022	16,86 undefined	1,34 undefined	1,43 undefined
2021	15,22 undefined	1,00 undefined	1,85 undefined
2020	11,82 undefined	1,03 undefined	1,43 undefined
2019	11,15 undefined	0,97 undefined	1,30 undefined
2018	9,88 undefined	0,91 undefined	1,07 undefined
2017	7,53 undefined	0,91 undefined	1,27 undefined
2016	6,28 undefined	0,71 undefined	1,20 undefined
2015	5,43 undefined	0,59 undefined	1,06 undefined
2014	5,24 undefined	0,48 undefined	0,92 undefined
2013	4,46 undefined	0,46 undefined	0,71 undefined
2012	3,28 undefined	0,25 undefined	0,70 undefined
2011	3,41 undefined	0,17 undefined	0,61 undefined
2010	2,42 undefined	0,09 undefined	0,46 undefined
2009	2,09 undefined	0,08 undefined	1,35 undefined
2008	2,03 undefined	0,06 undefined	0,37 undefined
2007	1,99 undefined	0,09 undefined	0,34 undefined
2006	2,20 undefined	0,05 undefined	0,14 undefined
2005	1,84 undefined	0,09 undefined	0,10 undefined
2004	1,50 undefined	0,09 undefined	0,13 undefined

	Pendapatan per Saham	EBIT per Saham	Laba per Saham
2004	1,50 CNY	0,09 CNY	0,13 CNY
2005	1,84 CNY	0,09 CNY	0,10 CNY
2006	2,20 CNY	0,05 CNY	0,14 CNY
2007	1,99 CNY	0,09 CNY	0,34 CNY
2008	2,03 CNY	0,06 CNY	0,37 CNY
2009	2,09 CNY	0,08 CNY	1,35 CNY
2010	2,42 CNY	0,09 CNY	0,46 CNY
2011	3,41 CNY	0,17 CNY	0,61 CNY
2012	3,28 CNY	0,25 CNY	0,70 CNY
2013	4,46 CNY	0,46 CNY	0,71 CNY
2014	5,24 CNY	0,48 CNY	0,92 CNY
2015	5,43 CNY	0,59 CNY	1,06 CNY
2016	6,28 CNY	0,71 CNY	1,20 CNY
2017	7,53 CNY	0,91 CNY	1,27 CNY
2018	9,88 CNY	0,91 CNY	1,07 CNY
2019	11,15 CNY	0,97 CNY	1,30 CNY
2020	11,82 CNY	1,03 CNY	1,43 CNY
2021	15,22 CNY	1,00 CNY	1,85 CNY
2022	16,86 CNY	1,34 CNY	1,43 CNY
2023	15,51 CNY	0,48 CNY	0,89 CNY
2024e	21,37 CNY	0 CNY	1,31 CNY
2025e	23,22 CNY	0 CNY	1,53 CNY
2026e	25,16 CNY	0 CNY	1,73 CNY

	Jumlah Saham
2004	1,61 miliar Aktien
2005	1,62 miliar Aktien
2006	1,86 miliar Aktien
2007	1,86 miliar Aktien
2008	1,86 miliar Aktien
2009	1,86 miliar Aktien
2010	1,89 miliar Aktien
2011	1,90 miliar Aktien
2012	2,24 miliar Aktien
2013	2,24 miliar Aktien
2014	2,30 miliar Aktien
2015	2,32 miliar Aktien
2016	2,33 miliar Aktien
2017	2,46 miliar Aktien
2018	2,52 miliar Aktien
2019	2,56 miliar Aktien
2020	2,56 miliar Aktien
2021	2,56 miliar Aktien
2022	2,61 miliar Aktien
2023	2,67 miliar Aktien
2024e	2,67 miliar Aktien
2025e	2,67 miliar Aktien
2026e	2,67 miliar Aktien

Tanggal	Shanghai Fosun Pharmaceutical Group Co Dividen
2026e	0,44 undefined
2025e	0,44 undefined
2024e	0,44 undefined
2023	0,42 undefined
2022	0,56 undefined
2021	0,43 undefined
2020	0,39 undefined
2019	0,32 undefined
2018	0,38 undefined
2017	0,35 undefined
2016	0,32 undefined
2015	0,28 undefined
2014	0,27 undefined
2013	0,21 undefined
2012	0,10 undefined
2011	0,10 undefined
2010	0,07 undefined
2009	0,07 undefined
2008	0,07 undefined
2007	0,05 undefined
2006	0,17 undefined
2005	0,08 undefined
2004	0,10 undefined

	Dividen	Dividen (Estimasi)
2004	0,10 CNY	0 CNY
2005	0,08 CNY	0 CNY
2006	0,17 CNY	0 CNY
2007	0,05 CNY	0 CNY
2008	0,07 CNY	0 CNY
2009	0,07 CNY	0 CNY
2010	0,07 CNY	0 CNY
2011	0,10 CNY	0 CNY
2012	0,10 CNY	0 CNY
2013	0,21 CNY	0 CNY
2014	0,27 CNY	0 CNY
2015	0,28 CNY	0 CNY
2016	0,32 CNY	0 CNY
2017	0,35 CNY	0 CNY
2018	0,38 CNY	0 CNY
2019	0,32 CNY	0 CNY
2020	0,39 CNY	0 CNY
2021	0,43 CNY	0 CNY
2022	0,56 CNY	0 CNY
2023	0,42 CNY	0 CNY
2024e	0 CNY	0,44 CNY
2025e	0 CNY	0,44 CNY
2026e	0 CNY	0,44 CNY

Tanggal	Shanghai Fosun Pharmaceutical Group Co Rasio Pembayaran Dividen
2026e	31,31 %
2025e	33,27 %
2024e	30,77 %
2023	29,89 %
2022	39,14 %
2021	23,27 %
2020	27,27 %
2019	24,62 %
2018	35,51 %
2017	27,56 %
2016	26,67 %
2015	26,42 %
2014	29,35 %
2013	29,58 %
2012	14,29 %
2011	16,39 %
2010	14,49 %
2009	4,94 %
2008	18,02 %
2007	15,08 %
2006	124,54 %
2005	76,92 %
2004	78,90 %

	Rasio Pembayaran Dividen
2004	78,90 %
2005	76,92 %
2006	124,54 %
2007	15,08 %
2008	18,02 %
2009	4,94 %
2010	14,49 %
2011	16,39 %
2012	14,29 %
2013	29,58 %
2014	29,35 %
2015	26,42 %
2016	26,67 %
2017	27,56 %
2018	35,51 %
2019	24,62 %
2020	27,27 %
2021	23,27 %
2022	39,14 %
2023	29,89 %
2024e	30,77 %
2025e	33,27 %
2026e	31,31 %

Tanggal	Estimasi EPS	EPS-Actual	Kuartal Laporan
31/3/2024	0,35	0,23 (-34,00 %)	2024 Q1
31/12/2023	0,41	0,04 (-90,22 %)	2023 Q4
30/9/2023	0,39	0,19 (-52,79 %)	2023 Q3
30/6/2023	0,33	0,30 (-8,62 %)	2023 Q2
31/3/2023	0,38	0,37 (-3,60 %)	2023 Q1
31/12/2022	0,38	0,48 (26,72 %)	2022 Q4
30/9/2022	0,41	0,34 (-16,89 %)	2022 Q3
30/6/2022	0,43	0,42 (-2,17 %)	2022 Q2
31/3/2022	0,37	0,18 (-51,83 %)	2022 Q1
31/12/2021	0,34	0,46 (33,95 %)	2021 Q4
30/9/2021	0,47	0,42 (-11,52 %)	2021 Q3
30/6/2021	0,96	0,33 (-65,61 %)	2021 Q2
31/3/2021	0,34	0,33 (-3,90 %)	2021 Q1
31/12/2020	0,44	0,46 (3,51 %)	2020 Q4
30/9/2020	0,31	0,30 (-4,18 %)	2020 Q3
30/6/2020	0,36	0,44 (22,70 %)	2020 Q2
31/3/2020	0,22	0,23 (6,73 %)	2020 Q1
31/12/2019	0,63	0,49 (-22,58 %)	2019 Q4
30/9/2019	0,29	0,22 (-23,58 %)	2019 Q3
30/6/2019	0,35	0,31 (-11,28 %)	2019 Q2
31/3/2019	0,33	0,28 (-14,71 %)	2019 Q1
31/12/2018	0,27	0,24 (-11,99 %)	2018 Q4
30/9/2018	0,35	0,20 (-43,42 %)	2018 Q3
30/6/2018	0,40	0,35 (-13,37 %)	2018 Q2
31/3/2018	0,33	0,28 (-15,99 %)	2018 Q1
31/12/2017	0,32	0,28 (-13,06 %)	2017 Q4
30/9/2017	0,31	0,29 (-7,53 %)	2017 Q3
30/6/2017	0,41	0,39 (-4,53 %)	2017 Q2
31/3/2017	0,31	0,31 (0,62 %)	2017 Q1
31/12/2016	0,29	0,26 (-11,23 %)	2016 Q4
30/9/2016	0,31	0,29 (-5,35 %)	2016 Q3
30/6/2016	0,35	0,37 (5,87 %)	2016 Q2
31/3/2016	0,28	0,27 (-4,53 %)	2016 Q1
31/12/2015	0,28	0,24 (-13,61 %)	2015 Q4
30/9/2015	0,30	0,25 (-17,49 %)	2015 Q3
30/6/2015	0,28	0,33 (16,69 %)	2015 Q2
31/3/2015	0,24	0,23 (-5,12 %)	2015 Q1
31/12/2014	0,28	0,23 (-19,10 %)	2014 Q4
30/9/2014	0,29	0,24 (-16,03 %)	2014 Q3
30/6/2014	0,34	0,25 (-25,04 %)	2014 Q2
31/12/2011	0,09	0,05 (-44,88 %)	2011 Q4

%	Nama	Saham	Perubahan	Tanggal
41,87 %	Shanghai Fosun High Technology (Group) Co., Ltd.	886.315.955	0	31/12/2023
1,14 %	China Merchants Fund Management Co. Ltd.	24.106.618	-818.400	31/12/2023
0,87 %	E Fund Management Co. Ltd.	18.389.093	-571.853	31/12/2023
0,54 %	Yinhua Fund Management Co., Ltd.	11.537.035	1.020.740	31/12/2023
0,44 %	Huatai-PineBridge Fund Management Co., Ltd.	9.369.625	1.212.600	31/12/2023
0,41 %	China Universal Asset Management Co., Ltd.	8.724.081	-835.598	31/12/2023
0,37 %	Yunnan Qijia Investment Co., Ltd.	7.896.749	0	31/12/2023
0,37 %	Tianhong Asset Management Co., Ltd.	7.866.489	0	31/12/2023
0,35 %	GF Fund Management Co., Ltd.	7.371.877	-1.100	31/12/2023
0,29 %	CITIC Securities Co., Ltd. (Asset Management)	6.162.837	6.162.837	31/12/2023
0,20 %	The Vanguard Group, Inc.	4.197.813	-281.800	31/3/2024
0,17 %	BlackRock Institutional Trust Company, N.A.	3.573.033	-39.000	31/3/2024
0,13 %	Harvest Fund Management Co., Ltd.	2.827.232	0	29/2/2024
0,13 %	HuaAn Fund Management Co., Ltd.	2.694.281	22.900	31/12/2023
0,12 %	BlackRock Advisors (UK) Limited	2.468.160	74.000	31/3/2024
0,11 %	Penghua Fund Management Co., Ltd.	2.257.391	2.026.300	30/6/2023
0,08 %	Hwabao WP Fund Management Co., Ltd.	1.693.700	1.639.900	30/6/2023
0,07 %	Fullgoal Fund Management Co., Ltd.	1.501.846	15.400	31/12/2023
0,07 %	Norges Bank Investment Management (NBIM)	1.380.948	-2.427.756	31/12/2023
0,07 %	Wu (Yifang)	1.380.100	0	31/12/2023
0,05 %	Guotai Asset Management Co., Ltd.	1.146.860	82.100	31/12/2023
0,05 %	Harvest Global Investments Limited	1.033.814	0	31/3/2024
0,05 %	Galaxy Asset Management Co., Ltd.	1.025.484	-1.200	31/12/2023
0,05 %	China Southern Asset Management Co. Ltd.	1.021.224	-5.800	31/12/2023
0,04 %	China Asset Management (Hong Kong) Limited	851.340	65.600	31/3/2024
0,04 %	Fortune & Royal Asset Management Company Limited	814.200	165.000	30/6/2023
0,04 %	ICBC Credit Suisse Asset Management Co. Ltd.	770.131	252.500	30/6/2023
0,03 %	DWS Investments UK Limited	728.976	-549	31/3/2024
0,03 %	Amundi Asset Management, SAS	712.160	181.060	31/3/2024
0,03 %	Essence Fund Management Co., Ltd.	580.002	1.500	31/12/2023
0,03 %	SWS MU Fund Management Co., Ltd.	549.552	-9.004	31/12/2023
0,02 %	Handelsbanken Kapitalförvaltning AB	498.700	0	31/3/2024
0,02 %	CITIC Prudential Fund Management Co., Ltd.	497.835	-1.400	31/12/2023
0,02 %	Wang (Ke Xin)	467.700	0	31/12/2023
0,02 %	Yao (Fang)	458.300	0	31/12/2023
0,02 %	CCB Principal Asset Management Co., Ltd.	430.646	-3.400	31/12/2023
0,02 %	Mellon Investments Corporation	427.577	-77.300	31/3/2024
0,02 %	State Street Global Advisors (US)	426.982	-12.500	31/3/2024
0,02 %	Guan (Xiao Hui)	418.100	0	31/12/2023
0,02 %	BlackRock (Singapore) Limited	369.335	79.900	31/3/2024
0,02 %	Taikang Asset Management Co., Ltd.	338.405	-3.800	30/6/2023
0,02 %	Geode Capital Management, L.L.C.	334.800	5.700	29/2/2024
0,01 %	Aviva Investors Global Services Limited	313.721	107.544	29/2/2024
0,01 %	Bosera Asset Management Co., Ltd.	286.200	98.357	31/12/2023
0,01 %	Tibet Eastmoney Fund Management Co., Ltd.	279.700	-26.600	31/12/2023
0,01 %	JPMorgan Asset Management (China) Company Limited.	273.000	23.500	30/6/2023
0,01 %	California State Teachers Retirement System	262.400	84.800	30/6/2023
0,01 %	State Street Global Advisors (UK) Ltd.	261.367	1	31/3/2024
0,01 %	UBS Asset Management (UK) Ltd.	248.800	300	31/3/2024
0,01 %	Credit Suisse Funds AG	231.712	-2.100	31/3/2024
0,01 %	Wen (Deyong)	227.100	0	31/12/2023
0,01 %	China Life AMP Asset Management Co., Ltd	207.600	17.500	31/12/2023
0,01 %	Krane Funds Advisors, LLC	186.929	4.600	31/3/2024
0,01 %	Nuveen LLC	183.988	0	31/3/2024
0,01 %	Northern Trust Global Investments Limited	178.000	0	29/2/2024
0,01 %	BlackRock Investment Management (UK) Ltd.	162.500	0	29/2/2024
0,01 %	Charles Schwab Investment Management, Inc.	161.200	0	31/3/2024
0,01 %	Amundi Japan Ltd.	160.600	3.300	31/3/2024
0,01 %	DWS Investment GmbH	155.075	-3.600	31/3/2024
0,01 %	Chen (Yu Qing)	154.000	0	31/12/2023
0,01 %	Florida State Board of Administration	143.600	93.000	30/9/2022
0,01 %	Nuode Asset Management Company Limited	142.500	23.900	30/6/2023
0,01 %	Changsheng Fund Management Co., Ltd.	141.864	-4.500	31/12/2023
0,01 %	CPIC Fund Management Co., Ltd.	138.654	-1.000	31/12/2023
0,01 %	Fubon Asset Management Company Ltd.	134.545	-12.300	29/2/2024
0,01 %	HSBC Global Asset Management (UK) Limited	130.882	200	29/2/2024
0,01 %	First Seafront Fund Management Co., Ltd.	125.951	0	31/12/2023
0,01 %	Huashang Fund Management Co., Ltd.	125.900	-658.300	30/6/2023
0,01 %	Hony Horizon Fund Management Co., Ltd.	121.000	2.700	30/6/2023
0,01 %	LBP AM	115.160	36.105	29/2/2024
0,01 %	UBS Asset Management (Switzerland)	114.200	0	29/2/2024
0,01 %	Chen (Qi Yu)	114.075	0	31/12/2023
0,01 %	Feng (Rongli)	113.500	0	31/12/2023
0,01 %	Wang (Donghua)	113.500	0	31/12/2023
0,01 %	Li (Jing)	113.500	0	31/12/2023
0,01 %	Caitong Fund Management Co., Ltd.	110.700	28.300	30/6/2023
0,01 %	PGGM Vermogensbeheer B.V.	110.010	-357	31/7/2023
0,00 %	Mercer Global Investments Management Ltd	103.200	0	31/3/2024
0,00 %	Pictet Asset Management Ltd.	99.600	-5.400	31/12/2023
0,00 %	Cardano Asset Management NV	97.176	97.176	29/2/2024
0,00 %	BOCI-Prudential Asset Management Ltd.	89.500	900	29/2/2024
0,00 %	ABC-CA Fund Management Co., Ltd.	84.442	-400	31/12/2023
0,00 %	Franklin Templeton Sealand Fund Management Co., Ltd.	83.200	83.172	30/6/2023
0,00 %	Dong (Xiao Xian)	81.800	0	31/12/2023
0,00 %	Mei (Jing Ping)	80.300	0	31/12/2023
0,00 %	Mirae Asset Global Investments Co., Ltd.	78.704	334	31/1/2024
0,00 %	Wanjia Asset Management Co., Ltd.	77.549	-2.500	31/12/2023
0,00 %	Founder Fubon Fund Management Co., Ltd.	70.900	-354.100	30/6/2023
0,00 %	Legal & General Investment Management Ltd.	70.900	-14.000	29/2/2024
0,00 %	CICC Fund Management Co Ltd.	70.300	5.400	31/12/2023
0,00 %	Xu (Aihua)	70.200	0	31/12/2023
0,00 %	Li (Dongjiu)	66.800	46.800	31/12/2023
0,00 %	Liu (Yi)	66.800	0	31/12/2023
0,00 %	Bao (Qingui)	66.800	0	31/12/2023
0,00 %	Minsheng Royal Fund Management Company Ltd.	65.943	-6.700	30/6/2023
0,00 %	PICC Asset Management Company Limited	64.500	24.200	30/6/2023
0,00 %	Manulife Fund Management Co., Ltd.	57.700	36.200	30/6/2023
0,00 %	Zhu (Yue)	56.800	0	31/12/2023
0,00 %	Hang Seng Investment Management Ltd.	53.975	-622	31/3/2024
0,00 %	Nykredit Bank AS	49.901	36.501	29/2/2024

What values and corporate philosophy does Shanghai Fosun Pharmaceutical Group Co represent?

Shanghai Fosun Pharmaceutical Group Co Ltd represents a set of core values and a strong corporate philosophy. With a focus on innovation, integrity, and social responsibility, the company strives to deliver high-quality pharmaceutical products and healthcare services. Shanghai Fosun Pharmaceutical Group Co Ltd believes in fostering sustainable development and prioritizes the well-being of patients and the community. The company's dedication to excellence, patient-centric approach, and continuous research and development efforts make it a prominent player in the pharmaceutical industry. Shanghai Fosun Pharmaceutical Group Co Ltd exemplifies a commitment to quality, ethical practices, and making a positive impact on society.

In which countries and regions is Shanghai Fosun Pharmaceutical Group Co primarily present?

The Shanghai Fosun Pharmaceutical Group Co Ltd primarily operates and has a significant presence in multiple countries and regions. The company is mainly active in China, where its headquarters is located. It also has a strong presence in various other regions and countries, including the United States, Europe, India, and Africa. Shanghai Fosun Pharmaceutical Group Co Ltd focuses on expanding its global footprint through strategic partnerships, collaborations, and acquisitions. With its diversified portfolio and global operations, the company continues to deliver innovative healthcare solutions and contribute to the well-being of people worldwide.

What significant milestones has the company Shanghai Fosun Pharmaceutical Group Co achieved?

Shanghai Fosun Pharmaceutical Group Co Ltd has achieved several significant milestones in its history. The company has demonstrated consistent growth and expansion, becoming one of the leading pharmaceutical companies in China. It has successfully developed and marketed various innovative drugs, contributing to improved healthcare outcomes for patients. Shanghai Fosun Pharmaceutical Group Co Ltd has also made strategic acquisitions and formed partnerships to strengthen its market presence both domestically and internationally. Additionally, the company has received recognition for its commitment to research and development, as well as its contributions to healthcare philanthropy. These achievements make Shanghai Fosun Pharmaceutical Group Co Ltd a formidable player in the pharmaceutical industry.

What is the history and background of the company Shanghai Fosun Pharmaceutical Group Co?

Shanghai Fosun Pharmaceutical Group Co Ltd, commonly known as Fosun Pharma, is a leading Chinese pharmaceutical company. Established in 1994, the company has a rich history and a strong background in the healthcare industry. Fosun Pharma focuses on research, development, manufacturing, and distribution of a wide range of pharmaceutical products, including prescription drugs, over-the-counter medicines, and medical devices. Over the years, Fosun Pharma has expanded its presence globally and has become one of the largest comprehensive healthcare groups in China. With a commitment to innovation and high-quality products, Shanghai Fosun Pharmaceutical Group Co Ltd continues to make significant contributions to the advancement of healthcare worldwide.

Who are the main competitors of Shanghai Fosun Pharmaceutical Group Co in the market?

The main competitors of Shanghai Fosun Pharmaceutical Group Co Ltd in the market include multinational pharmaceutical companies such as Johnson & Johnson, Pfizer, Novartis, and GlaxoSmithKline. These competitors are well-established players in the global pharmaceutical industry and offer a wide range of products and services similar to Shanghai Fosun Pharmaceutical Group. As Shanghai Fosun Pharmaceutical Group aims to expand globally and capture a larger market share, it faces strong competition from these industry giants. However, Shanghai Fosun Pharmaceutical Group has its unique strengths, product portfolio, and innovative strategies to differentiate itself and gain a competitive advantage in the market.

In which industries is Shanghai Fosun Pharmaceutical Group Co primarily active?

Shanghai Fosun Pharmaceutical Group Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Shanghai Fosun Pharmaceutical Group Co?

The business model of Shanghai Fosun Pharmaceutical Group Co Ltd focuses on various aspects of the pharmaceutical industry. As a leading healthcare company, it engages in research and development, manufacturing, sales, and distribution of pharmaceutical products. Shanghai Fosun Pharmaceutical Group Co Ltd is committed to promoting innovation and improving the accessibility of healthcare products and services. It operates through segments such as pharmaceutical manufacturing, research and development, distribution and retail, and medical services. By leveraging its strong industry expertise and strategic partnerships, Shanghai Fosun Pharmaceutical Group Co Ltd aims to contribute to the advancement of healthcare and provide high-quality medical solutions to customers worldwide.

Berapa KGV dari Shanghai Fosun Pharmaceutical Group Co 2024?

Rasio P/E Shanghai Fosun Pharmaceutical Group Co adalah 21,76.

KUV apa yang dimiliki oleh Shanghai Fosun Pharmaceutical Group Co 2024?

Rasio KUV dari Shanghai Fosun Pharmaceutical Group Co adalah 1,34.

Skor Kualitas AlleAktien apa yang dimiliki oleh Shanghai Fosun Pharmaceutical Group Co?

Skor Kualitas AlleAktien untuk Shanghai Fosun Pharmaceutical Group Co adalah 4/10.

Berapa jumlah pendapatan dari Shanghai Fosun Pharmaceutical Group Co 2024?

Omset diharapkan Shanghai Fosun Pharmaceutical Group Co adalah 45,24 miliar CNY.

Berapa besar keuntungan dari Shanghai Fosun Pharmaceutical Group Co 2024?

Laba diharapkan Shanghai Fosun Pharmaceutical Group Co adalah 2,78 miliar CNY.

Apa yang dilakukan Shanghai Fosun Pharmaceutical Group Co?

The Shanghai Fosun Pharmaceutical Group Co Ltd is a leading company in the development, manufacturing, and marketing of pharmaceutical products and medical services. The business model is based on a diversified portfolio of business activities focused on various segments of the healthcare industry. The company's first division is the manufacturing of pharmaceutical products. Shanghai Fosun Pharma produces a wide range of medical products, including drugs, diagnostics, and medical devices. The company specializes in innovative drug manufacturing to offer high-quality medical solutions to its customers, with a strong emphasis on product quality. Another important division is research and development. Shanghai Fosun Pharma invests significantly in researching and developing new drugs and therapies. The company collaborates closely with international partners to develop innovative technologies and products that meet market needs. In addition to these activities, the company also operates hospitals, healthcare centers, and care facilities. Shanghai Fosun Pharma is a leading provider of high-quality healthcare services in China. The company strives to offer its customers a comprehensive range of services focused on the needs of patients. Furthermore, the group also has a subsidiary, Fosun Industrial Co Ltd, specializing in the manufacturing and marketing of chemicals and plastic products. This perfectly complements the company's portfolio and enables it to serve more customers. The company also offers various health products, including dietary supplements, medical aids, and wellness products. These products are sold in the company's own pharmacies as well as retail pharmacies nationwide. Shanghai Fosun Pharma also operates in overseas markets, with branches in various countries around the world. The company aims to bring product quality and innovation to the global market in order to make them accessible to an even larger part of society. In summary, the business model of Shanghai Fosun Pharmaceutical Group Co Ltd is based on innovation and differentiation through research and development, manufacturing, and distribution of drugs, medical services, and products. The company has a strong presence in the healthcare market and delivers world-leading products and services.

Berapa besar dividen Shanghai Fosun Pharmaceutical Group Co?

Shanghai Fosun Pharmaceutical Group Co membayarkan dividen sebesar 0,56 CNY yang dibagi melalui pembayaran dalam setahun.

Berapa kali Shanghai Fosun Pharmaceutical Group Co membayar dividen?

Dividen untuk Shanghai Fosun Pharmaceutical Group Co saat ini tidak dapat dihitung atau perusahaan tidak membagikan dividen.

Apa itu ISIN Shanghai Fosun Pharmaceutical Group Co?

ISIN dari Shanghai Fosun Pharmaceutical Group Co adalah CNE000000X38.

Apa itu Ticker Shanghai Fosun Pharmaceutical Group Co?

Ticker dari Shanghai Fosun Pharmaceutical Group Co adalah 600196.SS.

Berapa banyak Dividen yang dibayarkan oleh Shanghai Fosun Pharmaceutical Group Co?

Dalam 12 bulan terakhir, Shanghai Fosun Pharmaceutical Group Co membayar dividen sebesar 0,42 CNY . Ini setara dengan yield dividen sekitar 1,85 %. Untuk 12 bulan mendatang, Shanghai Fosun Pharmaceutical Group Co diperkirakan akan membayar dividen sebesar 0,44 CNY.

Berapa tingkat dividen dari Shanghai Fosun Pharmaceutical Group Co?

Imbal hasil dividen dari Shanghai Fosun Pharmaceutical Group Co saat ini adalah 1,85 %.

Kapan Shanghai Fosun Pharmaceutical Group Co membayar dividen?

Shanghai Fosun Pharmaceutical Group Co membayar dividen setiap kuartal. Dividen ini dibayarkan pada bulan Agustus, Agustus, Juli, September.

Seberapa aman dividen dari Shanghai Fosun Pharmaceutical Group Co?

Shanghai Fosun Pharmaceutical Group Co membayar dividen setiap tahun dalam 23 tahun terakhir.

Berapa besar dividen dari Shanghai Fosun Pharmaceutical Group Co?

Untuk 12 bulan ke depan, diperkirakan akan ada dividen sebesar 0,44 CNY. Ini setara dengan yield dividen sebesar 1,92 %.

Di sektor manakah Shanghai Fosun Pharmaceutical Group Co berada?

Shanghai Fosun Pharmaceutical Group Co dikelompokkan dalam sektor 'Kesehatan'.

Wann musste ich die Aktien von Shanghai Fosun Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

Untuk menerima dividen terakhir dari Shanghai Fosun Pharmaceutical Group Co tanggal 9/8/2023 sejumlah 0,42 CNY, Anda harus memiliki saham tersebut di portofolio sebelum tanggal Ex-Tag pada 9/8/2023.

Kapan Shanghai Fosun Pharmaceutical Group Co membayar dividen terakhir?

Pembayaran dividen terakhir dilakukan pada 9/8/2023.

Berapa besarnya dividen dari Shanghai Fosun Pharmaceutical Group Co pada tahun 2023?

Pada tahun 2023, Shanghai Fosun Pharmaceutical Group Co 0,56 CNY telah dibayarkan sebagai dividen.

Dalam mata uang apa Shanghai Fosun Pharmaceutical Group Co membayar dividen?

Dividen dari Shanghai Fosun Pharmaceutical Group Co dibayarkan dalam CNY.

1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3,95
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,80	2,34
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50,00	-188,00
66,00	-37,00	-52,00	-107,00	-150,00	-199,00	-308,00	-347,00	-341,00	-497,00	-470,00	-570,00	-535,00	-1.220,00	-2.103,00	-3.171,00	-3.721,00	-4.956,00	-5.976,00	-7.424,00	-11.359,00	-13.569,00	-12.871,00	-15.073,00	-18.041,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2.996,00	-572,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-14,00	-24,00	-14,00	-40,00	-65,00	-129,00	-239,00	-205,00	-185,00	-184,00	-209,00	-336,00	-363,00	-616,00	-755,00	-963,00	-1.171,00	-1.395,00	-1.560,00	-1.959,00	-2.410,00	-2.275,00	-2.196,00	-1.836,00	-1.609,00
0,07	0,04	0,14	0,07	0,10	0,15	0,21	0,19	0,18	0,13	0,23	0,26	0,20	0,32	0,67	1,01	1,20	1,62	2,11	2,58	2,95	3,22	2,58	3,95	4,22
-52,00	-78,00	-126,00	-141,00	-139,00	-264,00	-205,00	-222,00	-266,00	-209,00	-210,00	-348,00	-339,00	-796,00	-1.160,00	-1.040,00	-1.119,00	-1.235,00	-1.922,00	-2.170,00	-3.174,00	-3.962,00	-4.437,00	-4.972,00	-5.888,00
-99,00	-238,00	-443,00	-487,00	-150,00	162,00	-779,00	-437,00	-336,00	-53,00	56,00	-397,00	-264,00	-1.766,00	-978,00	-1.803,00	-2.478,00	-1.869,00	-2.447,00	-10.504,00	-5.244,00	-172,00	-4.706,00	-3.856,00	-4.064,00
-0,05	-0,16	-0,32	-0,35	-0,01	0,43	-0,57	-0,22	-0,07	0,16	0,27	-0,05	0,07	-0,97	0,18	-0,76	-1,36	-0,63	-0,53	-8,33	-2,07	3,79	-0,27	1,12	1,82
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0,02	0,01	0,08	0,50	0,09	-0,29	0,16	0,35	0,80	0,38	-0,09	0,68	1,72	1,52	-0,46	-0,03	3,09	2,00	0,57	8,93	2,39	-2,44	2,25	1,81	3,75
372,00	77,00	435,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0,34	0,04	0,47	0,45	0,02	0,59	0,01	0,15	0,37	0,14	-0,35	0,40	1,82	0,91	2,07	-0,93	1,86	0,55	1,45	9,91	3,14	-1,94	1,47	-0,83	4,43
-0,00	-0,03	-0,04	0,04	0,02	0,98	0,01	0,03	-0,00	0,02	0,02	0,02	0,48	-0,06	3,23	0,15	-0,10	-0,34	2,07	2,41	4,30	2,37	1,05	-0,73	3,06
-7,00	-10,00	-4,00	-84,00	-91,00	-105,00	-149,00	-228,00	-428,00	-258,00	-277,00	-302,00	-378,00	-543,00	-707,00	-1.058,00	-1.126,00	-1.109,00	-1.193,00	-1.433,00	-3.551,00	-1.864,00	-1.834,00	-1.913,00	-2.374,00
0,32	-0,06	0,37	0,25	0,29	1,38	0,19	0,64	0,93	1,03	0,85	1,43	2,86	1,61	5,27	3,39	6,69	8,31	10,84	13,78	17,55	20,18	16,69	19,98	28,58
14,40	-39,80	11,80	-73,30	-37,00	-114,00	0,10	-34,30	-81,70	-78,20	22,40	-86,20	-135,80	-480,20	-495,10	-28,50	80,80	385,50	188,00	409,60	-224,80	-739,70	-1.857,30	-1.023,84	-1.671,27
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Emisi Langsung.	289.044
Emisi tidak langsung dari energi yang dibeli.	659.631
Emisi tidak langsung dalam rantai nilai	794
Emisi CO₂	948.675
Strategi Reduksi CO₂	✅
Energi Batubara	❌
Energi Nuklir	❌
Percobaan pada hewan	✅
Bulu & Kulit	—
Pestisida	—
Minyak Sawit	—
Tembakau	❌
Bioteknologi	❌
Konsep Iklim	—
Pengelolaan Hutan Berkelanjutan	—
Peraturan Daur Ulang	✅
Kemasan Ramah Lingkungan	✅
Bahan berbahaya	✅
Konsumsi dan Efisiensi Bahan Bakar	✅
Penggunaan dan Efisiensi Air	✅

Persentase Karyawan Wanita	48,48
Proporsi Wanita dalam Manajemen	—
Porsi Karyawan Asia	—
Porsi Manajemen Asia	—
Proporsi Karyawan Hispanik/Latino	—
Porsi Manajemen Hispanik/Latino	—
Porsi Karyawan Berkulit Hitam	—
Porsi Manajemen Hitam	—
Proporsi Karyawan Kulit Putih	—
Porsi manajemen berkulit putih	—
Konten Dewasa	❌
Alkohol	❌
Pertahanan	—
Senjata api	❌
Judi	❌
Kontrak Militer	❌
Konsep Hak Asasi Manusia	✅
Konsep Perlindungan Data	—
Kesehatan dan Keselamatan Kerja	✅
Katolik	✅

Laporan Keberlanjutan	✅
Stakeholder-Engagement	✅
Kebijakan Pemanggilan Kembali	❌
Hukum Anti Monopoli	❌

Shanghai Fosun Pharmaceutical Group Co Ticker	Shanghai Fosun Pharmaceutical Group Co FIGI
600196:CH	BBG000C4SR52
600196:CG	BBG000C4SRF1
600196:C1	BBG00709HHX2

1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0,19	0,34	0,49	0,57	0,73	1,03	2,16	2,43	2,99	4,08	3,69	3,77	3,87	4,56	6,49	7,34	10,00	12,03	12,61	14,63	18,53	24,92	28,59	30,31	39,01	43,95	41,40	45,24	49,15	53,25
-	78,95	43,24	16,43	28,40	41,76	108,82	12,53	23,26	36,57	-9,53	2,17	2,62	17,64	42,39	13,18	36,17	20,31	4,85	16,02	26,69	34,44	14,72	6,02	28,70	12,68	-5,81	9,29	8,63	8,35
36,84	37,06	42,71	43,56	37,23	34,40	26,91	31,22	29,98	21,34	26,59	27,67	32,02	33,90	37,63	43,62	44,22	43,87	49,78	53,81	58,84	58,34	59,57	55,47	47,97	47,09	47,54	-	-	-
0,07	0,13	0,21	0,25	0,27	0,36	0,58	0,76	0,90	0,87	0,98	1,04	1,24	1,54	2,44	3,20	4,42	5,28	6,28	7,87	10,91	14,54	17,03	16,81	18,71	20,70	19,68	0	0	0
0,05	0,07	0,11	0,10	0,08	0,07	0,06	0,15	0,14	0,09	0,16	0,12	0,16	0,16	0,32	0,55	1,03	1,11	1,36	1,64	2,24	2,29	2,49	2,64	2,55	3,50	1,29	2,41	2,75	2,71
27,37	20,88	21,77	17,11	10,44	6,88	2,92	6,31	4,78	2,25	4,44	3,13	4,05	3,58	5,00	7,53	10,30	9,19	10,81	11,23	12,06	9,17	8,71	8,72	6,54	7,97	3,10	5,33	5,59	5,09
0,04	0,06	0,09	0,10	0,14	0,15	0,26	0,22	0,16	0,26	0,63	0,69	2,50	0,86	1,17	1,56	1,58	2,11	2,46	2,81	3,12	2,71	3,32	3,66	4,74	3,73	2,39	2,78	3,24	3,67
-	55,00	50,00	10,75	38,83	2,80	76,19	-16,99	-26,05	62,26	142,64	10,38	261,51	-65,41	34,95	34,13	1,21	33,48	16,42	14,07	11,33	-13,32	22,67	10,26	29,27	-21,22	-36,03	16,55	16,33	13,51
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0,55	1,42	1,42	1,49	1,49	1,49	1,49	1,61	1,62	1,86	1,86	1,86	1,86	1,89	1,90	2,24	2,24	2,30	2,32	2,33	2,46	2,52	2,56	2,56	2,56	2,61	2,67	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Lakukan investasi terbaik dalam hidupmu fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Harga saham

Harga saham

Ticker600196.SS

ISINCNE000000X38

Shanghai Fosun Pharmaceutical Group Co Saham Pendapatan, EBIT, Laba CNE000000X38 ·

Pendapatan, Laba & EBIT

Pemahaman Pendapatan, EBIT dan Penghasilan

Analisis Tahunan dan Perbandingan

Memanfaatkan Harapan Investasi

Wawasan Investasi

Shanghai Fosun Pharmaceutical Group Co Omzet, Laba, dan Histori EBIT

Shanghai Fosun Pharmaceutical Group Co Saham Kennzahlen

GuV

Pendapatan dan Pertumbuhan

Margin Bruto

EBIT dan Margin EBIT

Pendapatan dan Pertumbuhan

Saham yang Beredar

Interpretasi Perbandingan Tahunan

Ekspektasi dan Prakiraan

Neraca

Memahami Neraca

Aset

Kewajiban

Ekuitas

Analisis Tahun Demi Tahun

Interpretasi Data

Shanghai Fosun Pharmaceutical Group Co Saham Marjin CNE000000X38 ·

Margen

Pemahaman Margin Kotor

Analisis Margin EBIT

Wawasan Margin Penjualan

Menginterpretasikan Harapan

Analisis Komparatif

Shanghai Fosun Pharmaceutical Group Co Sejarah Margin

Shanghai Fosun Pharmaceutical Group Co Saham Pendapatan, EBIT, Laba per Saham CNE000000X38 ·

Pendapatan, EBIT dan Laba per Saham

Pendapatan per Saham

EBIT per Saham

Pendapatan per Saham

Nilai yang Diharapkan

Shanghai Fosun Pharmaceutical Group Co Pendapatan, Laba, dan EBIT per Saham Sejarah

Shanghai Fosun Pharmaceutical Group Co Saham dan Analisis Saham

Shanghai Fosun Pharmaceutical Group Co Penilaian berdasarkan KGV, EBIT, dan KUV historis

Shanghai Fosun Pharmaceutical Group Co Jumlah Saham CNE000000X38 ·

Pendapatan, EBIT dan Laba per Saham

Pendapatan per Saham

EBIT per Saham

Pendapatan per Saham

Nilai yang Diharapkan

Shanghai Fosun Pharmaceutical Group Co Pemecahan Saham

Shanghai Fosun Pharmaceutical Group Co Dividen Saham CNE000000X38 ·

Dividen

Tinjauan atas Dividen

Interpretasi dan Penggunaan

Strategi Investasi

Shanghai Fosun Pharmaceutical Group Co Sejarah Dividen

Shanghai Fosun Pharmaceutical Group Co Rasio Pembayaran Dividen CNE000000X38 ·

Ausschüttungsquote

Apa itu rasio pembagian dividen tahunan?

Cara Menginterpretasikan Data

Penggunaan Data untuk Investasi

Shanghai Fosun Pharmaceutical Group Co Sejarah Rasio Pembagian Dividen

Shanghai Fosun Pharmaceutical Group Co Estimasi Pendapatan

Shanghai Fosun Pharmaceutical Group Co Kejutan Laba

Rating Eulerpool ESG untuk saham Shanghai Fosun Pharmaceutical Group Co

Eulerpool World ESG Rating (EESG©)

95/ 100

🌱 Environment

👫 Social

🏛️ Governance

Lingkungan (Environment)

Sosial (Social)

Tata Kelola Perusahaan (Governance)

Shanghai Fosun Pharmaceutical Group Co Struktur Pemegang Saham Aktie

Shanghai Fosun Pharmaceutical Group Co Dewan Direksi dan Dewan Komisaris

Pertanyaan Umum tentang Saham Shanghai Fosun Pharmaceutical Group Co

What values and corporate philosophy does Shanghai Fosun Pharmaceutical Group Co represent?

In which countries and regions is Shanghai Fosun Pharmaceutical Group Co primarily present?

Lakukan investasi terbaik dalam hidupmu
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Ticker
600196.SS

ISIN
CNE000000X38